Patents by Inventor Mohan Prasad

Mohan Prasad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130005777
    Abstract: The present invention provides sorafenib ethane sulphonate, process for its preparation, pharmaceutical composition comprising sorafenib ethane sulphonate and its use for the treatment of cancer. Formula (III).
    Type: Application
    Filed: November 12, 2010
    Publication date: January 3, 2013
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Jagdev Singh Jaryal, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • Publication number: 20130005980
    Abstract: The present invention provides a process for the preparation of sorafenib tosylate, comprising contacting sorafenib free base with p-toluenesulphonic acid in water.
    Type: Application
    Filed: September 24, 2010
    Publication date: January 3, 2013
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Jagdev Singh Jaryal, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • Publication number: 20120309842
    Abstract: The present invention provides processes and intermediates for preparing cinacalcet base and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: September 16, 2010
    Publication date: December 6, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Sayeed Mukhtar, Dinesh Shashidharan Nair, Roshan Ramesh Medhane, Nitin Maheshwari, Hashim Nizar Poovanathil Nagoor Meeran, Neera Tewari, Mohan Prasad
  • Publication number: 20120302749
    Abstract: The present invention relates to processes for the preparation of erlotinib hydrochloride Form A and erlotinib hydrochloride Form B. (I).
    Type: Application
    Filed: November 12, 2010
    Publication date: November 29, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Balaguru Murugesan, Anandam Vempali, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • Publication number: 20120283440
    Abstract: The present invention relates to crystalline forms of bosentan salts and processes for their preparation.
    Type: Application
    Filed: November 12, 2010
    Publication date: November 8, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Rakesh Singh, Anu Mittal, Gopal Singh Bisht, Mahavir Singh Khanna, Rajesh Kumar Thaper, Mohan Prasad
  • Publication number: 20120277426
    Abstract: The present invention provides a process for preparation of crystalline aprepitant having not more than 15% by weight of Form I content which comprises, a) dissolving aprepitant in a suitable solvent to obtain a solution, b) cooling the solution to 10-15° C., c) optionally seeding the solution with aprepitant Form I crystals, d) adding an anti-solvent to the solution, and e) isolating crystalline aprepitant having not more than 15% by weight of Form I content.
    Type: Application
    Filed: June 2, 2010
    Publication date: November 1, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Deepak Mohanlal Jain, Maneck Khurana, Hiten Sharadchandra Mehta, Abhay Tatiya, Asok Nath, Sanjay Mahadeo Gade, Mohan Prasad, Subhash Dhar
  • Publication number: 20120271056
    Abstract: The present invention relates to a process for the preparation of crystalline Form I of the L-malic acid salt of sunitinib.
    Type: Application
    Filed: November 12, 2010
    Publication date: October 25, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Sudhir Singh Sanwal, Saridi Madhava Dileep Kumar, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • Publication number: 20120267533
    Abstract: The present invention relates to processes for the preparation of Form I and Form II of palonosetron hydrochloride. The present invention further relates to a method of determining the polymorphic forms of palonosetron hydrochloride using Fourier-Transform Infra-red (FTIR) method.
    Type: Application
    Filed: June 30, 2010
    Publication date: October 25, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Gyanendra Pandey, Kaptan Singh, Surender Dhingra, Mohan Prasad, Tippasandra G. Chandrashekhar, Somenath Ganguly, Rita Santhakumar
  • Publication number: 20120264789
    Abstract: The present invention provides amorphous and crystalline forms of acid addition salts of sorafenib, pharmaceutical compositions comprising them and their use for the treatment of cancer. The present invention also provides processes for the preparation of acid addition salts of sorafenib.
    Type: Application
    Filed: September 24, 2010
    Publication date: October 18, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Jagdev Singh Jaryal, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • Publication number: 20120220777
    Abstract: The present invention relates to an in-situ process for the preparation of polymorphic Form A of lenalidomide.
    Type: Application
    Filed: September 16, 2010
    Publication date: August 30, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Saridi Madhava Dileep Kumar, Munish Kapoor, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • Publication number: 20120220783
    Abstract: The present invention relates to salts of sunitinib and their preparation.
    Type: Application
    Filed: September 16, 2010
    Publication date: August 30, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Sudhir Singh Sanwal, Saridi Madhava Dileep Kumar, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • Publication number: 20120190849
    Abstract: The present invention provides processes for the preparation of vardenafil, its pharmaceutically acceptable salts, hydrates and intermediates.
    Type: Application
    Filed: August 9, 2010
    Publication date: July 26, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Anu Mittal, Mahavir Singh Khanna, Rajesh Kumar Thaper, Mohan Prasad
  • Publication number: 20120184746
    Abstract: The present invention relates to a process for the preparation of lenalidomide, wherein the process comprises: reducing 3-(4-nitro-loxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione to obtain lenalidomide.
    Type: Application
    Filed: September 3, 2010
    Publication date: July 19, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Munish Kapoor, Saridi Madhava Dileep Kumar, Balaguru Murugesan, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • Publication number: 20120184750
    Abstract: The present invention provides an improved process for the preparation of olmesartan medoxomil, which is free of OLM-acid and has lower amount of eliminate and acetic acid impurity.
    Type: Application
    Filed: May 20, 2010
    Publication date: July 19, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Ashwini Kumar Kapoor, Hiten Sharadchandra Mehta, Asok Nath, Mohan Prasad
  • Publication number: 20120184751
    Abstract: The present invention relates to a polymorphic form of olmesartan medoxomil and a process for the preparation of crystalline olmesartan medoxomil.
    Type: Application
    Filed: July 29, 2010
    Publication date: July 19, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Ashwini Kumar Kapoor, Hiten Sharadchandra Mehta, Asok Nath, Mohan Prasad
  • Publication number: 20120178821
    Abstract: The present invention provides a polymorphic form of toremifene citrate and processes for its preparation. It also relates to an improved process for the preparation of the Z isomer of the toremifene base, free of E isomer, and its pharmaceutically acceptable salts.
    Type: Application
    Filed: July 30, 2010
    Publication date: July 12, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Pranab Chatterjee, Asok Nath, Mohan Prasad
  • Patent number: 8178674
    Abstract: The invention relates to processes for the preparation of substantially pure ziprasidone. The invention also relates to the preparation of acid addition salts of ziprasidone. More particularly, it relates to the preparation of substantially pure hydrochloride salt of ziprasidone. The invention also relates to pharmaceutical compositions that include the substantially pure ziprasidone or ziprasidone hydrochloride and use of said compositions for treating schizophrenia.
    Type: Grant
    Filed: May 4, 2011
    Date of Patent: May 15, 2012
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Yatendra Kumar, Mohan Prasad, Mahivir Singh Khanna, Seema Ahuja
  • Publication number: 20120101272
    Abstract: The present invention relates to a process for preparation of erlotinib of Formula I or its pharmaceutically acceptable salt thereof. The present invention also relates to process for the preparation of erlotinib trifluoroacetate. The present invention also relates to a nove-ICrystalline form of erlotinib trifluoroacetate designated as Form E and process for its preparation. The present invention further relates to process for the preparation of erlotinib hydrochloride from erlotinib trifluoroacetate.
    Type: Application
    Filed: March 26, 2010
    Publication date: April 26, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Balaguru Murugesan, Anandam Vempali, Swargam Sathyanarayana, Rajesh Kumar Thaper, Mohan Prasad
  • Publication number: 20120101281
    Abstract: The present invention provides a process for the preparation of desloratadine comprising contacting loratadine with a mixture of a weak inorganic base and sodium or potassium hydroxide in a ratio, ranging from 0.01 to 0.15 equivalents of sodium or potassium hydroxide per equivalent of weak inorganic base, in one or more suitable solvents) followed by isolation.
    Type: Application
    Filed: March 26, 2010
    Publication date: April 26, 2012
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Balaguru Murugesan, Swargam Sathyanarayana, Mohan Prasad
  • Publication number: 20120070470
    Abstract: Compositions that include a clay such as kaolin dispersed in a liquid such as water may be useful for promoting the clotting of blood. The compositions may be in a liquid, gel, paste, foam, or another form. Uses may include treating a traumatic injury such as in injury caused by a bullet, an explosive, a blade etc., or an injury caused during a medical procedure such as surgery.
    Type: Application
    Filed: September 22, 2011
    Publication date: March 22, 2012
    Applicant: Z-Medica Corporation
    Inventors: Mohan Prasad Pahari, Giacomo Basadonna, Denny Lo